The oncogene eIF4E: using biochemical insights to target cancer

Area of Science:

• Molecular Biology
• Cancer Biology
• Biochemistry

Background:

• The eukaryotic translation initiation factor eIF4E is frequently overexpressed in human cancers, correlating with poor patient prognosis.
• eIF4E acts as a central regulator of post-transcriptional gene expression, essential for mRNA translation, export, and stability.
• It plays a critical role in modulating the expression of genes involved in cell proliferation and survival.

Purpose of the Study:

• To review the multifaceted roles of eIF4E in cellular processes and cancer.
• To elucidate the regulatory mechanisms controlling eIF4E activity.
• To discuss current and emerging therapeutic strategies targeting eIF4E.

Main Methods:

• Literature review of eIF4E function, regulation, and therapeutic targeting.
• Analysis of signaling pathways (e.g., Ras, MAPK, PI3K/mTOR) that converge on eIF4E.
• Examination of preclinical and clinical data for eIF4E-targeted therapies.

Main Results:

• eIF4E's critical function in mRNA cap binding underlies its role in translation initiation.
• eIF4E activity is tightly regulated by protein-protein interactions and signaling pathways.
• Dysregulation of eIF4E contributes to oncogenesis by promoting the translation of specific mRNAs.

Conclusions:

• eIF4E is a key oncogenic driver and a promising therapeutic target in various human malignancies.
• Understanding eIF4E's regulatory network is crucial for developing effective cancer treatments.
• Targeting eIF4E presents a viable strategy with ongoing preclinical and clinical investigations.